CLINICAL_TRIALS
trial_result
· 2014-09-01
Clinical Trial Update: Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study A (MK-4305-028) [Phase 3]
Summary
Phase 3 trial update on suvorexant for primary insomnia, reporting safety and efficacy results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Primary Insomnia | Phase 3 | Status: COMPLETED | Results posted: 2014-09-01